This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1981 Jul-Aug;6(4):275-97.

doi: 10.2165/00003088-198106040-00003.

Influence of thyroid dysfunction on drug pharmacokinetics

PMID: 6166422
DOI: 10.2165/00003088-198106040-00003

Review

Influence of thyroid dysfunction on drug pharmacokinetics

G M Shenfield. Clin Pharmacokinet. 1981 Jul-Aug.

. 1981 Jul-Aug;6(4):275-97.

doi: 10.2165/00003088-198106040-00003.

Author

PMID: 6166422
DOI: 10.2165/00003088-198106040-00003

No abstract available

PubMed Disclaimer

Similar articles

Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Feely J. Feely J. Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001. Clin Pharmacokinet. 1983. PMID: 6132696 Review. No abstract available.
Drug pharmacokinetics in thyroid dysfunction.
Rodighiero V. Rodighiero V. Minerva Endocrinol. 1985 Apr-Jun;10(2):97-113. Minerva Endocrinol. 1985. PMID: 2415808 Review. No abstract available.
[A study of the kinetics of cardiac glycosides in the human organism].
van Zwieten PA. van Zwieten PA. Ned Tijdschr Geneeskd. 1971 Jan 23;115(4):157-62. Ned Tijdschr Geneeskd. 1971. PMID: 4926491 Review. Dutch. No abstract available.
[Influence of thyroid function on human drug metabolism].
Gugler R, Eichelbaum M, Schneider-Deters C, Bodem G, Dengler HJ. Gugler R, et al. Verh Dtsch Ges Inn Med. 1973;79:1230-3. Verh Dtsch Ges Inn Med. 1973. PMID: 4790145 German. No abstract available.
[Influence of thyroid dysfunction on pharmacokinetics and pharmacodynamics of drugs].
Ostermann G, Freneaux E, Lejeunne C, Durlach V, Gross A, Leutenegger M. Ostermann G, et al. Therapie. 1988 Jun-Jul;43(4):285-91. Therapie. 1988. PMID: 3055406 Review. French. No abstract available.

See all similar articles

Cited by

P-glycoprotein polymorphism in hypo- and hyper-thyroidism patients.
Turgut G, Baştemir M, Turgut S, Akin F, Kursunluoglu R, Kaptanoğlu B. Turgut G, et al. Mol Biol Rep. 2008 Dec;35(4):693-8. doi: 10.1007/s11033-007-9142-y. Epub 2007 Sep 21. Mol Biol Rep. 2008. PMID: 17891478
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
O'Connor P, Feely J. O'Connor P, et al. Clin Pharmacokinet. 1987 Dec;13(6):345-64. doi: 10.2165/00003088-198713060-00001. Clin Pharmacokinet. 1987. PMID: 3325214 Review.
Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism.
Hashimoto Y, Yasuhara M, Kamiya A, Okumura K, Hori R. Hashimoto Y, et al. Br J Pharmacol. 1989 Jan;96(1):163-9. doi: 10.1111/j.1476-5381.1989.tb11796.x. Br J Pharmacol. 1989. PMID: 2924068 Free PMC article.
Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Feely J. Feely J. Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001. Clin Pharmacokinet. 1983. PMID: 6132696 Review. No abstract available.
Impaired nitrazepam metabolism in hypothyroidism.
Kenny RA, Kafetz K, Cox M, Timmers J, Impallomeni M. Kenny RA, et al. Postgrad Med J. 1984 Apr;60(702):296-7. doi: 10.1136/pgmj.60.702.296. Postgrad Med J. 1984. PMID: 6728755 Free PMC article.

See all "Cited by" articles

References

1. Nephron. 1975;15(3-5):223-49 - PubMed
1. Biochem Pharmacol. 1961 Jun;6:257-62 - PubMed
1. Acta Pharmacol Toxicol (Copenh). 1974 Nov;35(5):361-9 - PubMed
1. Mol Pharmacol. 1978 Jan;14(1):122-9 - PubMed
1. Drug Metab Dispos. 1973 Sep-Oct;1(5):687-90 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information